SHIRE PLC: Director/PDMR Shareholding

Director/PDMR Share Dealings 
September 30, 2013 - Shire plc (LSE: SHP, NASDAQ: SHPG) announces that Graham
Hetherington was granted on September 27, 2013, under the Shire Sharesave
Scheme, an option over 467 ordinary shares at an exercise price of £19.24 per
share. 
This notification relates to disclosures made in accordance with 3.1.4(R)(1)(a)
of the Disclosure and Transparency Rules. 
Tony Guthrie
Deputy Company Secretary 
For further information please contact: 
Investor Relations                                                              
                                                                           
Eric Rojas                              erojas@shire.com     +1 781 482 0999    
                                                                           
Sarah Elton-Farr                        seltonfarr@shire.com +44 1256 894157    
Notes to editors 
Shire enables people with life-altering conditions to lead better lives. 
Our strategy is to focus on developing and marketing innovative specialty
medicines to meet significant unmet patient needs. 
We provide treatments in Neuroscience, Rare Diseases, Gastrointestinal,
Internal Medicine and Regenerative Medicine and we are developing treatments
for symptomatic conditions treated by specialist physicians in other targeted
therapeutic areas. 
www.shire.com 
                                                                         
Registered in Jersey, No. 99854, 22 Grenville Street, St Helier, Jersey JE4 8PX 
Press Release                                      
                                              
www.shire.com                                      
END 
-0- Sep/30/2013 15:15 GMT
 
 
Press spacebar to pause and continue. Press esc to stop.